NeonMind Engages Leading Digital Platform for Medical Education and Adoption of Ketamine Treatments in Preparation of… Apr 19, 2022
NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments Mar 10, 2022
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate… Nov 23, 2021
NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for… Nov 8, 2021
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine Nov 5, 2021
Who Will Pay For Psychedelic Assisted Therapy? Neonmind CEO Rob Tessarolo On Insurance Companies And More Oct 18, 2021
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board Sep 16, 2021
